Basel, Switzerland, 21 October 2014 – Lonza is pleased to provide some guidance on the use of its portfolio of disinfectants and disinfectant cleaners as part of an infection control program for the Ebola virus.
On 1 August 2014, the U.S. Centers for Disease Control and Prevention (CDC) released guidance titled “Infection Prevention and Control Recommendations for Hospitalized Patients with Known or Suspected Ebola Hemorrhagic Fever in U.S. Hospitals”1
The CDC states in part: “Ebola viruses are transmitted through direct contact with blood or body fluids/substances (e.g., urine, feces, vomit) of an infected person with symptoms or through exposure to objects (such as needles) that have been contaminated with infected blood or body fluids. The role of the environment in transmission has not been established”.
It continues to say that, as part of the program of care of persons with probable or confirmed Ebola virus infections, hospitals are recommended to “Use a U.S. Environmental Protection Agency (EPA)-registered hospital disinfectant with a label claim for a non-enveloped virus (e.g., norovirus, rotavirus, adenovirus, poliovirus) to disinfect environmental surfaces in rooms of patients with suspected or confirmed Ebola virus infection”.
Separately, and in specific reference to “Environmental infection control”, the CDC has stated “Appropriate disinfectants for Ebola virus and other filoviruses include…hospital-grade quaternary ammonium…products”2
In addition, within Europe, the current EN 14885:2006 standard “Application of European Standards for Chemical Disinfectants and Antiseptics” stipulates that for a “virucidal” claim to be made for hard surface and instrument disinfectants, efficacy against poliovirus and adenovirus needs to be demonstrated using the EN 14476:2005 test protocol.
Lonza is a leading global manufacturer of disinfectants and disinfectant cleaners, many with supported label claims for viruses including those identified by U.S. CDC and within EN 14885:2006. Lonza offers for sale disinfectants with specific claims against target organisms as approved for the jurisdiction in which each product is sold.
¨ Available within Lonza’s U.S. portfolio are several product families that meet the CDC guidance to use products having efficacy against non-enveloped viruses including Bardac® 205M, Lonzagard® HWS, Lonzagard® R-82, Lonzagard® RCS and Lonzagard® Disinfectant Wipes. In Europe, Lonzagard® DR-25aN Disinfectant Cleaner can make “virucidal” claims according to standards set by EN 14885:2006.
Lonza also offers HTH® Calcium Hypochlorite, a multi-purpose disinfectant and sanitizer. Chlorine products are widely recognized and recommended by international health authorities and used by non-governmental organizations. HTH® Calcium Hypochlorite has been registered for the sanitation of drinking and waste water and for the disinfection of hard surfaces, vehicles and containers, among other uses.
For further information, please find a list of your local regional contacts:
| NAFTA |
Todd Miller | todd.miller@lonza.com | +1 678 442 1001 |
| EMEA |
Anna Guest |
anna.guest@lonza.com |
+44 161 721 2023 |
| Japan |
Kazuaki
Chiba |
kazuaki.chiba@lonza.com
kazuhide.kawasaki@lonza.com |
+81 3 6264 0600 |
| China |
Hareton Liu |
hareton.liu@lonza.com |
+86 21 63403488 (Ext. 5871) |
| South East Asia |
Nelson Tan |
nelson.tan@lonza.com |
+65 6521 4364 |
| Latin America |
Vinicius Bim |
vinicius.bim@lonza.com |
+55
11 4501 1226
|
| India |
Shilpa Pange |
shilpa.pange@lonza.com |
+91 22 4342 4017 |
1 https://www.cdc.gov/vhf/ebola/hcp/infection-prevention-and-control-recommendations.html
2 https://emergency.cdc.gov/han/han00364.asp